Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Total Current Liabilities
All obligations due within one year.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total current liabilities rises 54.4% from a year ago
Total current liabilities stood at $164.31M at the end of Q2 FY2026, up 54.4% from a year earlier and up 31.4% from the prior quarter. Over 3 fiscal years it compounded at +49.2% a year.
Context
- Total current liabilities amounted to 8.5% of total assets at the end of Q2 FY2026, up 0.1 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +54.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 133.04M USD
- Year-over-year change
- +53.7%
- 3-year CAGR
- +49.2%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 133.04M | +53.7% |
| FY2024 | 2024-12-31 | 86.54M | +146.7% |
| FY2023 | 2023-12-31 | 35.08M | -12.5% |
| FY2022 | 2022-12-31 | 40.09M | — |
Total Current Liabilities vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's Jun 2026 total current liabilities of $164.31M is the lowest of the 7 companies compared; the peer median is $2.76B.
- Its year-over-year change of +54.4% is the 3rd highest of 7, against a peer median of +0.5%.
- Total current liabilities amounts to 8.5% of total assets for ALAB, versus a peer median of 10.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Aug 2026 | $5.66B | +89.9% | +9.9% | 11.7% | |
| Jun 2026 | $4.66B | -6.6% | +3.4% | 17.9% | |
| Sep 2026 | $3.02B | -3.2% | +1.9% | 8.2% | |
| Aug 2026 | $2.5B | +4.2% | +10.5% | 9.1% | |
| Aug 2026 | $198.17M | +82.8% | +85.2% | 6.6% | |
| Sep 2026 | $176.42M | -3.9% | -18.3% | 19.3% | |
| Jun 2026 | $164.31M | +54.4% | +49.2% | 8.5% | |
| Peer median (excluding ALAB) | $2.76B | +0.5% | +6.7% | 10.4% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.